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Abstract 
The objective of this paper is to describe how qualitative methods can be used in the development of descriptive 
systems of preference based measures (PBM) of health related quality of life.  
 
The requirements of NICE and other agencies together with increasing use of patient reported outcome 
measures has lead to an increase in the demand for PBM. Recently, interest has grown in developing new PBM 
and whilst previous research on PBM has mainly focused on the methods of valuation, research into the 
methods of developing descriptive systems is an emerging field.  
   
Traditionally, descriptive systems of PBMs were developed using top down methods, where content was 
derived from existing measures, the literature, or health surveys. A contrasting approach is a bottom up 
methodology, which takes the views of patients or lay people on how their life is affected by their health. This 
approach generally requires the use of qualitative methods. Qualitative methods lend themselves well to the 
development of PBMs. They also ensure the measure has appropriate language, content validity and 
responsiveness to change. Whilst the use of qualitative methods in the development of non PBMs is fairly 
standard, their use in developing PBMs was until recently nonexistent.  
 
In this paper, we illustrate the use of qualitative methods by presenting two case studies of recently developed 
PBMs; one generic and one condition specific. We outline the stages involved, discuss the strengths and 
weaknesses of the approach and compare with the top down approach used in the majority of PBMs to date. 
  
Introduction 
The need to develop rigorous methods for effectively describing the impact of healthcare interventions on 
patients has been driven by two factors.  The first is the desire to collect data on the quality of care from the 
patient’s rather than the clinician’s perspective.  The second is the need to compare interventions, through 
economic evaluation, in order to use limited health care resources more efficiently.  Both of these make use of 
questionnaires that seek to obtain information from the patient regarding their health related quality of life, and 
are often referred to as Patient Reported Outcome Measures (PROMS).   
PROMs use within the UK National Health Service (NHS) was stimulated by a key recommendation of the 
Darzi report, “High Quality Care for all” [1] published under the last Labour Government.  This recommended 
that  the impact of treatments on quality of life should be measured through the routine use of PROMs. As a 
result, since 2009 NHS providers have been required to ask patients to complete a PROM before and after four 
surgical procedures (hip replacements, knee replacements, hernia repair, and varicose veins). These data are 
now published on a monthly basis.  The General Election in 2009 resulted in a change of Government but did 
not decrease the importance of PROMs within the NHS.  The Coalition Government’s White Paper: Liberating 
the NHS: Transparency in outcomes - a framework for the NHS [2], also stressed the importance of PROMs and 
advocated their more widespread use.   
The use of economic evaluation as a tool to aid health care resource allocation decision making has increased 
markedly in recent years and has been formalised in many countries through agencies such as the National 
Institute for Health and Clinical Excellence (NICE) in the UK [3] and others around the world [4], [5], [6]. 
These decision making bodies require evidence on the cost effectiveness of health care interventions under 
consideration as part of the decision making process. The majority of these agencies have formal guidelines for 
the methods of economic evaluation and whilst in the past these guidelines have not stipulated the measure of 
benefit for cost effectiveness analysis, more recently they have explicitly stated that health effects be measured 
in quality adjusted life years (QALYs) [3], [4], [6]. In 2004 NICE introduced its reference case (the set of 
methods considered most appropriate by NICE) and stated QALYs as the measure of benefit. All submissions to 
NICE now require a cost effectiveness analysis based on these methods with health effects measured in QALYs 
[3]. The QALY combines length of life and quality of life into a single summary measure. As well as being able 
to take account of changes in quality of life, quantity of life or both, it is useful in health care resource allocation 
decision making as it allows comparison across clinical areas due to the use of a common measure of benefit 
[7].  
 
QALYs are calculated as the product of the time spent in a particular health state multiplied by the utility or 
preference weight associated with that health state. This preference weight is on a scale where 1 is perfect health 
and 0 is equivalent to being dead (with negative values for health states judged to be worse than dead). These 
preference weights for health states can be obtained in a number of different ways, including the use of expert 
opinion, literature, direct valuation from the patient or the use of preference based measures (PBM) [7]. PBM 
are a type of PROM that typically consist of a health state classification system (HSCS) and a set of preference 
weights for each of the health states defined by the HSCS. Usually, patients complete the HSCS which defines 
their current health state and then the preference weight assigned to that health state can be used to calculate 
QALYs.  
 
Preference Based Measures 
There are two main types of PBM; generic and condition specific. A generic PBM is intended to cover all areas 
of health and should be applicable to any clinical condition. An example is the EQ5D which has been widely 
used in numerous clinical conditions [8]. A condition specific PBM is only concerned with a particular 
condition, for example asthma or diabetes.  They may be used when there are concerns that a generic PBM may 
not be valid or reliable, for example by not being sensitive enough. Examples include the SQOL 3D for sexual 
quality of life [9] and the AQL5D for asthma [10]. An alternative is to develop extra dimensions or “bolt-ons” to 
fill any important gaps identified in the coverage of a generic measure [10]. 
  
Generic PBMs such as the EQ-5D, SF-6D, HUI2 and HUI3 have sometimes been found to be inappropriate or 
insensitive for some conditions [7]. If a generic measure is not regarded as appropriate, then a condition specific 
PBM could be developed which would be relevant to the condition. The most common method to date to do this 
has been to modify an existing condition specific non PBM [11] however an alternative is to develop a new 
measure from scratch. Other reasons for developing a new PBM are for specific populations such as children, 
adolescents or the elderly where it is felt that the existing measures (mainly adult generics) are not appropriate 
for these populations.  
 
The main constraint of developing a PBM is that the health states defined by the HSCS should be amenable to 
valuation. Health state valuation is the way in which the preference weights for the health states are determined. 
It can be undertaken using a variety of methods including standard gamble, time trade or ordinal methods such 
as ranking and discrete choice experiments [7]. To be amenable to health state valuation, HSCS should have 
dimensions with ordinal levels and ideally one item per dimension. In addition, there is a limit to the number of 
dimensions that it can contain.  Typically people can value 7 (plus or minus 2) pieces of information at any one 
time [12] and so the number of dimensions is typically no more than 9. The most widely used generic 
descriptive systems range from 5 to 9 dimensions [7]. This is a practical constraint on the number of dimensions 
within a descriptive system as it is unlikely that respondents would be able to handle a larger number when 
undertaking valuation exercises. Non PBMs of HRQoL do not have to operate within these constraints and 
hence can have much larger descriptive systems. 
 
The requirements of NICE and other agencies together with increasing use of PROMS in the NHS has lead to an 
increase in the use of PBM in health care research and as a consequence, an increase in the demand for PBM. In 
the past, attention has been focused on the methods of health state valuation and less on the methods of 
developing the HSCS. Recently however, there has been increasing interest in developing new PBMs, 
particularly condition specific ones[11] and so there is increasing interest in the methods of development.  
 
Methods of Development 
The main existing generic PBM for adults have all used a top down approach in the development of their 
descriptive systems, that is, the content has been derived from existing literature, instruments and health 
surveys. The Measurement and Valuation of Health Survey which was used to develop the EQ-5D, used 196 
members of the general population to validate five existing descriptive systems, by surveying lay concepts [13]. 
The Quality of Well Being (QWB) drew its items mainly from an existing US Health Interview Survey and 
Social Security Administration Survey [14] the SF-36 (from which the SF-6D is derived) used data from 
existing instruments [15]  and the Assessment of Quality of Life (AQOL) was developed from a literature 
review from 1970 and interviews and focus groups with 24 clinicians [16]. The HUI2 was developed from a 
review of epidemiological surveys and a review of the literature which generated a large pool of potential 
attributes. They then used a sample of child and parent pairs to rate these items, to select attributes for inclusion. 
The Health Utilities Index 3 (HUI3) was developed from the HUI2 by increasing the number of dimensions to 8 
(through the separating out of some dimensions and the removal of others) and increasing the number of levels 
for all dimensions to between 5 and 6 [17].  
 
Three more recently developed generic PBMs for children are the AQoLY [18], the EQ5DY [19] and the 
CHU9D [20], [21], [22]. Both the AQoLY and the EQ5DY were developed using top down methods, as they 
have been adapted from the existing adult versions of their measures (AQoL and EQ5D respectively). In 
contrast, the CHU9D was developed using bottom up qualitative methods and is one of the case studies outlined 
in this paper.  
 
In a recent systematic review of condition specific PBM, Rowen [11] found that just over half (12 out of 22) of 
condition specific PBM identified were derived from a single non PBM for the condition of interest, often using 
a combination of factor, psychometric and Rasch analyses to determine a HSCS that is amenable to health state 
valuation. The other 10 had developed “de novo” classification systems, of which 7 used a top down approach 
of taking items and/or dimensions from either existing questionnaires, the literature or expert opinion. They also 
refined these items/ dimensions using a combination of psychometric techniques and some limited qualitative 
research.  
 
The remaining 3 measures were developed based on qualitative research. Unfortunately they provided little 
detail about their methodology but tended to  interview patients using semi structured or unstructured interviews 
and then used an expert panel to select domains and create levels for these domains. None of these measures 
were developed to be QALY measures intended for health care resource allocation, their stated purpose was as a 
clinically useful outcome measure. All three followed the same valuation method and had anchors on the 0 
worst state and 100 best state scale, hence they were not consistent with the QALY model of 0 dead 100 perfect 
health.  
 
The review by Rowen concluded that the majority of studies poorly described the methodology used to develop 
the measures, particularly the development of their classification system. This lack of detail contributes to the 
difficulty of developing robust methodology in this area. Rowen recommends that further research is need to 
examine best practice and to provide recommendations for the development of CSPBM [11].  
 
A contrasting approach to the top down methods that have been described is a bottom up methodology. This 
takes the views of patients or lay people, and seeks their input on how their quality of life is affected by their 
health problem or condition. This approach generally requires the use of qualitative methods to generate the 
items or content of the descriptive system, either through the use of focus groups or individual interviews [23].  
 
The first application of using a bottom up methodology with qualitative methods to develop a measure intended 
for use in economic evaluation (although not as a QALY measure) was undertaken by Grewal et al [25]  in their 
development of a QoL measure for older people. In this work, they interviewed people over 65 years of age to 
determine attributes for a new index focusing on QoL for older people. They conducted in depth interviews with 
40 participants to explore their views about what was important to them in terms of QoL. From these interview 
data they directly developed five conceptual attributes. This approach of determining attributes or dimensions 
directly is in contrast to the more common approach taken in the general QoL instrument development literature, 
where large lists of items are generated from interviews, the literature and/or opinion and then a technique such 
as factor analysis is used to develop the dimensions [26], [27]. The advantages of the bottom up approach are 
that the final measure developed will have appropriate language and terminology for the population which 
should increase the content validity. It is also likely to improve responsiveness to change, as it will ensure that 
outcomes of relevance to the patient are included [23]. A further benefit of this bottom up approach is that it ties 
in with the NHS priorities of putting the patient at the centre of decision making, providing patient centred care, 
and public-patient involvement in health care and research.  In more recent years, the importance of involving 
patients and lay people in the development of all types of QoL measures has been more widely recognised [24] 
and whilst the use of qualitative methods in the development of non PBMs is now fairly standard, their use in 
developing PBMs for use in economic evaluation was until recently nonexistent.  
 
 
The use of Qualitative Research  
There are a number of critical stages in qualitative research design [28]. The first of which is to review your 
research question and decide what type of qualitative data you require. For the development of PBM, generated 
data is usually required, which is data generated by respondents who give their own interpretation and 
explanation from interviews, as opposed to naturally occurring data that you may observe in a natural setting.  
This is appropriate because you need to generate the data by asking individuals about how their health affects 
them, this is not something that would be naturally occurring and you could observe. Secondly your data unit 
and time span need to be considered, for example case studies of individuals and whether at a point in time 
(cross sectional) or over a series of time points. The development of a PBM most likely demands cross sectional 
data as you are interested in views across the spectrum and not how people’s views change over time. Thirdly a 
data collection method needs to be determined, for example focus groups or individual interviews. Fourthly, you 
need to devise your sampling strategy and finally an analytical approach (e.g. thematic content analysis) needs 
to be determined, which will largely depend upon the purpose of the research, and can be aided with a data 
management tool such as NVIVO.  
 
These four stages of qualitative research design can be applied to the process of developing the descriptive 
systems of PBM. This process can be defined in 5 stages and each stage requires a series of key choices. These 
stages are summarized below and then outlined in more detail.  
 
1. Identify who to interview (data unit) 
2. Data collection method 
3. Interview/focus group design 
4. Analysis 
5. Development of the descriptive system 
 
1. Identify who to interview (data unit) 
Firstly, a decision has to be made about the relevant population(s) to interview. Perhaps the most relevant 
population, particularly for a condition specific PBM is the patient population who have the condition, as they 
have first hand knowledge about how it affects their life. Other relevant populations could include carers, family 
members, medical professionals or other experts. One important reason for focusing on the patient population is 
that others can either overestimate or underestimate the impact of a disease on quality of life [29].  For example, 
clinicians tend to be more generic and less focused, and to underestimate the social and subjective aspects of a 
disease compared to patients [30].  Once the decision regarding who to include is made, thought needs to be 
given to the sampling frame used. If interviewing patients, they could be sampled purposively on the basis of 
their health, so as to include as wide a range as possible. Other sampling criteria could include age, gender and 
ethnicity to ensure that a wide range of views are incorporated.  
 2. Data collection method 
There is a choice to be made between using focus groups, individual interviews or a combination of the two. 
Individual interviews offer more sensitivity and depth whereas focus groups allow participants to feed off each 
others ideas and can stimulate more discussion. In a focus group participants can feel more comfortable, 
however if the material being discussed is sensitive, it may be better to do individual interviews as they give the 
opportunity for complete privacy. Focus groups may lead to inhibitions in raising issues that some may feel are 
important, yet others do not and so they are unwilling to share them. However, individual interviews can feel 
uncomfortable for shy people and some may feel nervous. Thomas et al [31] found that there was no difference 
in terms of the depth of data generated between focus groups and interviews. Interviews and focus groups can 
also be used to complement each other and ensure a breadth of data are obtained.  For example focus groups 
could provide the initial analysis which can then be explored in more depth by individual interviews or focus 
groups could be used to validate data obtained from interviews [32], [33]. Ultimately the choice between these 
two methods of data collection needs to be decided with reference to the population being considered and the 
practical advantages and disadvantages of each method [23].  
 
3. Interview/focus group design 
An important consideration for the development of PBMs is whether to bring existing material to the interview 
or focus group, for example using prompts or suggestions from the literature or other sources, or to have a blank 
canvas. The advantage of using prompts is that they can help to stimulate ideas and make use of the existing 
knowledge base and evidence. The advantage of having a blank canvas is that there is no bias and no pre 
conceived ideas are introduced.  Effective interviewing is a complex skill and interviewers need the appropriate 
training.  Unstructured interviews can be particularly difficult to conduct and is a skill that needs practice and 
reflection [34].  Semi-structured interviews generally use a topic guide and provide the interviewer with an 
interview schedule and prompts in order to direct the interviewee but allow them to explore other areas where 
appropriate [35].  
 
4. Analysis  
Before analysing the data, it is important to check whether data saturation has been achieved, that is, when no 
new data is emerging from the interviews or focus groups[28]. It is important to achieve saturation for the 
development of PBMs in order to make sure that all areas of health related quality of life are captured by the 
measure.  
 
When analysing the data, there are two general approaches that can be taken. Firstly, items can be identified 
from the interviews and then dimensions developed from these, perhaps through the use of factor or Rasch 
analysis. This mirrors the approach taken in the general QoL literature for instrument development [36]. 
Alternatively, the use of qualitative methods allows for the identification of dimensions directly from the data, 
such as that referred to earlier by Grewal [25].  
 
5. Development of the descriptive system 
Lastly, once dimensions have been identified, levels need to be developed in order to form a HSCS amenable to 
valuation. The first decision is whether the levels should be based on the frequency or severity of a particular 
dimension. For example a dimension about pain could be either about the frequency of the pain or the severity 
of the pain. This choice may depend on the nature of the condition if developing a condition specific PBM or 
may be related to the purpose of the instrument. Qualitative data could be used to inform this choice by 
examining the way in which the dimensions or items were described in the interview and/or focus groups. Once 
this decision is made, wording for the levels needs to be developed. Existing scales, such as those from existing 
instruments or standard Likert type scales could be used or an alternative approach would be to develop new 
ones using the qualitative data.  
 
Case Studies to illustrate the use of qualitative techniques in the development of PBMs. 
Recent research by Stevens [20]  and Palfreyman [37], [38] took a bottom up methodology to the development 
of new PBMs using qualitative methods. We present both of these as case studies in the context of the key 
stages outlined above. The Child Health Utility 9D (CHU9D) is a preference based generic paediatric health 
related quality of life measure originally developed for children age 7-11 years [20] although there is now 
emerging evidence of it’s validity in an adolescent population [39]. The Sheffield Preference-based Venous 
Ulcer questionnaire (SPVU-5D) is a condition-specific preference based instrument that was developed for use 
with venous leg ulceration. 
  
Stage 1: Identify who to interview 
For the CHU9D, potential relevant populations to consider included parents/guardians, paediatric health care 
professionals, the general population, health care decision makers and children. All these were considered and 
children were chosen as the population to interview. This was because they were seen as the most relevant as 
they were the population the measure was intended for. By interviewing children, content validity would be 
increased Error! Bookmark not defined.and the language and terminology would be more 
appropriate than using the views of others. In addition, there is evidence that parent’s views are affected by their 
own health status, knowledge, experience and expectations [40]. There may also be areas or contexts of the 
child’s life that are unknown or less well known to parents such as school [41]. Drotar [42] also notes that many 
children are capable of recognizing and appreciating aspects of their own health, such as symptoms and the 
impact of changes in their health which their parents may not notice.  Purposive sampling was used with a 
primary criteria of age, followed by level of health (as rated by the parent) to ensure that the views of a full 
range of health across the ages were covered [20]. Secondary criteria were gender and ethnicity.  
 
For the SPVU-5D, both patient and professional perspectives were sought in developing the instrument.  
Although patients were central to the identification of the items for inclusion it was felt important to include the 
views of health professionals.  This was in order to check that no important aspects were omitted and to further 
validate the items that were identified by the patients.  A final consideration was that if health professionals 
were potentially to use the final instrument they had to be stakeholders in its development. For patients, 
purposive sampling was used in order to ensure that participants recruited approximated the range of ages, sex, 
and ethnicity attending the leg ulcer clinics in Sheffield. Purposive sampling was also used to ensure that the full 
range of clinicians involved in the care of venous ulcer patients were included.  The sample included medical 
and nursing staff from both primary and secondary care involved in the care. 
 
Both the CHU9D and SPVU-5D instruments used a purposive sampling approach in order to include the breadth 
of experiences of health of their respective populations. The aim was not to achieve statistical 
representativeness, but to capture the experience of health through identifying groups who possessed 
characteristics relevant to the health conditions being studied [28].  
 
Stage 2: Data collection method 
For the CHU9D, in choosing between focus groups and individual interviews several considerations pertinent to 
children were relevant. The advantage of focus groups is that children can feel more comfortable and feed off 
each other’s ideas, however the material being discussed was sensitive. In addition, pre existing dynamics 
within the groups of children selected can have an influence. Individual interviews give the opportunity for 
complete privacy and the opportunity for children to raise any issues that they wish. Individual interviews were 
chosen primarily because of the sensitivity of the topic and also because of the practicalities of managing young 
children in interview/groups situations; it is easier to manage an individual interview than a focus group of 
young children.  
 
For the SPVU-5D both interviews and focus groups were used to collect data.  The aim was for these to provide 
different sources of information and perspectives.  One benefit of focus groups is the added data obtained 
through the interaction of the members.  Using two different methods of data collection had the benefit of 
providing validation of the data interpretation from the semi-structured interviews and as a means to ensure that 
data saturation had been achieved.  
 
Contrasting approaches were taken in developing the two instruments due to the nature of the populations 
interviewed and type of instrument being developed.  It would not have been realistic to expect young children 
to participate in focus groups.  Another issue was imposed by the nature of the instruments being developed.  
The CHUD9D being a generic measure meant that interviewees may have raised a range of health problems.  
However, the SPVU5D was a condition specific measure so respondents were more likely to feel comfortable in 
a focus group as they all shared the same experience of one particular health problem/illness.  
 
Stage3: Interview/focus group design 
For the CHU9D a semi structured interview format was used, using a topic guide to ensure that each interview 
covered the same general questions (asking the child about their health problems and the impact on their lives). 
The topic guide did not include any items from the literature or existing instruments to use as prompts or 
discussion points as it was felt that these may have been developed for a different purpose and/or may not be the 
views of children and as there is a danger of acquiescence bias with children, including pre existing data may 
lead or bias the direction of the interview and what the children think. The interviews were therefore not 
influenced by preconceptions about what should be included. As this measure was developed with the intention 
of being child centred, it was felt that including data from other view points would conflict with this.  
 
For the SPVU-5D a semi-structured interview format was used but the interview schedule was generated from a 
review of the literature which highlighted specific symptoms and areas for exploration.  The issues and areas 
that arose in earlier interviews, which gave insights into the impact of venous ulceration on quality of life, 
influenced the focus and discussion of subsequent interviews.  A number of participants were also re-
interviewed and were presented with the data analysis in order to check that it was a valid interpretation of the 
interviews.   
 
Although the basis of the interview schedule for the two instruments differed, both techniques are equally valid. 
Using the literature to highlight areas for exploration can have the benefit of including a wider experience of the 
health problem and can also ensure that the final instrument incorporates any shortcomings of existing 
measures.  The alternative of allowing the participants to direct the interviews has the advantage of grounding 
the instrument more firmly within their experience.  Care has to be taken with this approach to ensure that data 
saturation has been reached and that no key areas have been missed. 
 
Stage 4: Analysis 
As the CHU9D was being developed specifically to be a PBM, the approach to the analysis was to identify 
dimensions directly from the data and then to develop levels for each of these as this suits the structure needed 
for a PBM. Thematic content analysis was used as it suits the approach of generating dimensions from this type 
of interview data. The analysis was guided by the research question; how does health affect children’s lives, and 
the aim was to identify dimensions of their HRQoL[20].  
 
For the SPVU-5D a thematic analysis of the data was undertaken using Framework analysis techniques [43]. It 
is particularly suitable for studies within public health and where there are clear aims at the outset – in this case 
identification of items for inclusion in a quality of life instrument [44].  The interpretation of the data was 
examined through re-interviewing a number of participants and through using a focus group as method of 
triangulation. This method aimed to ensure that the analysis had resonance with the experience of venous ulcer 
patients and that data saturation had been achieved. 
 Both instruments sought to ensure that the qualitative data was “trustworthy” and  “dependable” [45], [46].  This 
aims to demonstrate that the interpretation of the data was grounded in the data and not the researcher’s 
preconceived ideas.  In addition, the SPVU-5D included triangulation and member checking (or respondent 
validation).  Triangulation in qualitative research is essentially the use of different methods and perspectives in 
order to move away from a reliance on a single source of data so allowing the researcher to check the breadth of 
the data collection and the verification of the interpretation of the data [28]. 
 
Stage 5: Development of the descriptive system 
For the CHU9D the qualitative data was used to inform whether the dimensions would be frequency or severity 
based [21], by examining the ways in which the children described the dimensions. This has the advantage of 
ensuring that the resulting descriptive system accurately reflects how children think about and describe their 
HRQoL. This led to the dimensions being severity based which also suits a descriptive system with a short 
recall period which is desirable for a paediatric measure [47]. The qualitative data was again used to develop 
levels for all the dimensions as there were no suitable existing scales in the paediatric literature [21]. The 
advantage of using the qualitative data in this way is that the terminology of the children is retained in the 
measure and the validity and practicality of the measure should therefore be increased.  
 
For the SPVU-5D the qualitative data was used to identify items to be incorporated into the new instrument.  
For some items it was clear from the qualitative interviews that severity and frequency were an issue.  People 
were concerned with how severe and frequently pain occurred or how offensive and frequently their legs 
smelled.  For other items it was how often they were able to undertake a specific activity or the frequency with 
which a problem impacted on their quality of life rather than the severity of the impact.  A choice was made to 
have five levels within the dimensions in order to impose a limit on the potential number of health states.  The 
wording for the levels was based on a review of the current instruments and intended to reflect the same 
ordering as the other instruments but also aiming to ensure clear separation between the item levels.  A recall 
period of seven days was chosen based on the treatment regime for venous ulceration which is based around 
compression bandages being usually being left in place for a week. The wording of the questions and the 
ordering of the levels of the dimensions was assessed by piloting the questionnaire on a convenience sample of 
clinicians and patients.  
 The development of the descriptive system of both measures was informed by the qualitative data and the 
approach to the analysis. In the case of the CHU9D, this lead to dimensions being developed directly and their 
type (frequency or severity) and scales being informed by the qualitative data. In the case of the SPVU-5D, the 
qualitative data again informed whether the dimensions of the instrument should be severity or frequency based.  
For some of the items, it was clear from the qualitative interviews that both severity and frequency were an 
issue, e.g. people were concerned with how severe and frequently pain occurred.   
 
Discussion  
Although both the case studies described above used qualitative methods in the development of their descriptive 
systems, they differed in a number of ways with regard to the choices made at each stage in the development of 
the instruments. This was often dictated by the type of measure and the intended population. Both measures 
used a similar approach to sampling, in order to achieve a breadth of experience. They also used qualitative data 
to develop the content of the instrument and to inform the development of the levels of the HSCS.  
 For the SPVU-5D condition specific measure the use of focus groups was more likely to increase the richness 
of the data collection due to the shared experience of the disease. Within the focus group participants can “feed 
off” each others experience. Whereas for the generic measure the aim was to cover a range of clinical conditions 
and so the focus groups would have been heterogeneous resulting in a lack of a shared experience.  
 
 
A bottom up methodology using qualitative methods offers several advantages over the traditional top down 
approach. By involving patients and/or lay people, the HSCS will contain appropriate language and terminology 
and the dimensions will be of relevance to the population being studied, ensuring greater content and face 
validity. In addition, the measure will be more patient centred and as it will capture outcomes of relevance to 
patients, this means it is more likely to be responsive to change [48]. Taking a bottom up methodology ensures 
that the measure is developed according to its purpose, rather than relying on information from previous 
research that may have had different aims and objectives. 
 
Measures developed using bottom up methodology are more amenable to self completion by the patient which is 
desirable as it is increasingly recognized in clinical trials and health services research that descriptions of the 
experience of a health state should be elicited from the patients in order to reflect the actual experience of the 
disease and its treatment [49]. As the CHU9D was developed using bottom up methodology, it is much more 
likely that children will be able to self complete as the language and terminology was all determined by 
children. If a child can provide reliable and valid data, then self report is the optimal [50]. Similarly, the SPVU-
5D should be very amenable to self completion by the patient.  
 
Qualitative approaches can be used to either generate dimensions directly or to develop a long list of items 
which then requires further quantitative work to classify these items into dimensions. Both of these differing 
approaches have been illustrated in this paper. The key difference in the approach of generating dimensions 
directly is that it is perhaps easier to develop a PBM since it generates one item per dimension and levels within 
these in order to construct a HSCS. This is the ideal for health state valuation. In contrast, the item generation 
approach has a stronger use and reliance on psychometric techniques to develop the dimensions.  
 
Finally, before valuation, it is important that the descriptive system developed is tested to ensure it is a valid and 
reliable measure [51].  
 
Conclusions  
In this paper we have outlined the importance of using qualitative methods in developing descriptive systems for 
PBM used in economic evaluations. We have described the stages involved and illustrated these through the use 
of two case studies.  
 
The recent increase in the number of PBMs means that more attention needs to be paid to the methods used in 
their development. Particular attention needs be focused on the development of the descriptive systems for 
PBMs, an area which has received very little attention in the past. The use of a bottom up methodology offers 
several advantages in this respect over the use of the more traditional top down approach used by the majority of 
existing PBMs. Content and face validity should be increased and the measure will contain more appropriate 
language and terminology.  In addition, the dimensions will be of relevance to the population being studied and 
the measure will be more patient centred and amenable to self completion.  Using this bottom-up methodology 
means that PBMs can be developed for purpose rather than having to rely on data from existing instruments.  
These may have been developed for other purposes rather than for use in health care resource allocation decision 
making. The use of qualitative techniques means that PBMs will be more likely to have a valid and reliable 
descriptive system.  This should be the standard for any PROM and further research in this area for PBM is 
required.  
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